These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7981444)

  • 1. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.
    Fabian CJ; Zalles C; Kamel S; Kimler BF; McKittrick R; Tranin AS; Zeiger S; Moore WP; Hassanein RS; Simon C
    Breast Cancer Res Treat; 1994; 30(3):263-74. PubMed ID: 7981444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
    Fabian CJ; Kamel S; Zalles C; Kimler BF
    J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
    Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
    J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker and cytologic abnormalities in women at high and low risk for breast cancer.
    Fabian CJ; Zalles C; Kamel S; McKittrick R; Moore WP; Zeiger S; Simon C; Kimler B; Cramer A; Garcia F
    J Cell Biochem Suppl; 1993; 17G():153-60. PubMed ID: 7911861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.
    Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Kamel S; Zeiger S; Mayo MS
    J Natl Cancer Inst; 2000 Aug; 92(15):1217-27. PubMed ID: 10922407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA aneuploidy in relation to the combination of analysis of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancers.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Oncology; 2002; 63(1):48-55. PubMed ID: 12187071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
    Sharma AK; Horgan K; Douglas-Jones A; McClelland R; Gee J; Nicholson R
    Br J Cancer; 1994 Jun; 69(6):1032-7. PubMed ID: 8198966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
    Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
    Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.
    Stearns V; Fackler MJ; Hafeez S; Bujanda ZL; Chatterton RT; Jacobs LK; Khouri NF; Ivancic D; Kenney K; Shehata C; Jeter SC; Wolfman JA; Zalles CM; Huang P; Khan SA; Sukumar S
    Cancer Prev Res (Phila); 2016 Aug; 9(8):673-682. PubMed ID: 27261491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers.
    Moe RE; Moe KS; Porter P; Gown AM; Ellis G; Tapper D
    Am J Surg; 1991 May; 161(5):580-3. PubMed ID: 1674411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
    Giltnane JM; Rydén L; Cregger M; Bendahl PO; Jirström K; Rimm DL
    J Clin Oncol; 2007 Jul; 25(21):3007-14. PubMed ID: 17634479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1993 Jul; 72(1):131-6. PubMed ID: 8508397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
    Poller DN; Snead DR; Roberts EC; Galea M; Bell JA; Gilmour A; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1993 Jul; 68(1):156-61. PubMed ID: 8100443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE; André S; Pereira T; Silva G; Soares J
    Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Fabian CJ; Kimler BF
    Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer.
    Mori T; Morimoto T; Komaki K; Monden Y
    Cancer; 1991 Aug; 68(3):532-7. PubMed ID: 2065272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
    Kute TE; Muss HB; Hopkins M; Marshall R; Case D; Kammire L
    Breast Cancer Res Treat; 1985; 6(2):113-21. PubMed ID: 4052638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.
    Detre SI; Ashley S; Mohammed K; Smith IE; Powles TJ; Dowsett M
    Cancer Prev Res (Phila); 2017 Mar; 10(3):171-176. PubMed ID: 28100469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.